Format

Send to

Choose Destination
Infect Control Hosp Epidemiol. 2003 Jun;24(6):397-402.

An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska.

Author information

1
Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska 99508, USA.

Abstract

OBJECTIVE:

We investigated a large outbreak of community-onset methicillin-resistant Staphylococcus aureus (MRSA) infections in southwestern Alaska to determine the extent of these infections and whether MRSA isolates were likely community acquired.

DESIGN:

Retrospective cohort study.

SETTING:

Rural southwestern Alaska.

PATIENTS:

All patients with a history of culture-confirmed S. aureus infection from March 1, 1999, through August 10, 2000.

RESULTS:

More than 80% of culture-confirmed S. aureus infections were methicillin resistant, and 84% of MRSA infections involved skin or soft tissue; invasive disease was rare. Most (77%) of the patients with MRSA skin infections had community-acquired MRSA (no hospitalization, surgery, dialysis, indwelling line or catheter, or admission to a long-term-care facility in the 12 months before infection). Patients with MRSA skin infections were more likely to have received a prescription for an antimicrobial agent in the 180 days before infection than were patients with methicillin-susceptible S. aureus skin infections.

CONCLUSIONS:

Our findings indicate that the epidemiology of MRSA in rural southwestern Alaska has changed and suggest that the emergence of community-onset MRSA in this region was not related to spread of a hospital organism. Treatment guidelines were developed recommending that beta-lactam antimicrobial agents not be used as a first-line therapy for suspected S. aureus infections.

PMID:
12828314
DOI:
10.1086/502221
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center